Enable job alerts via email!
Boost your interview chances
Create a job specific, tailored resume for higher success rate.
This innovative firm is seeking an Associate Director to lead commercial insights and analytics for its early pipeline. The role involves synthesizing competitive intelligence and strategic insights to support preclinical and clinical programs, ultimately shaping the strategy for transformative therapies. With a focus on oncology and a commitment to improving patient lives, this position offers a unique opportunity to impact the future of biopharmaceuticals. Join a passionate team dedicated to pioneering solutions in healthcare and making a difference for patients with serious diseases. If you thrive in a dynamic environment and are eager to contribute to meaningful advancements, this role is for you.
Remote, New Haven - Headquarters, Hybrid
Arvinas is a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. Arvinas uses its proprietary PROTAC Discovery Engine platform to engineer proteolysis targeting chimeras, or PROTAC targeted protein degraders, that are designed to harness the body’s own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins.
In addition to its robust preclinical pipeline of PROTAC protein degraders against validated and “undruggable” targets, the company has three investigational clinical-stage programs currently enrolling: vepdegestrant for the treatment of patients with locally advanced or metastatic ER+/HER2- breast cancer; ARV-102 for the treatment of patients with neurodegenerative disorders, and ARV-393 for the treatment of patients with relapsed/refractory non-Hodgkin Lymphoma and potentially other lymphomas.
In April 2024, Arvinas entered into a transaction with Novartis, including a global license agreement for the development and commercialization of the clinical stage PROTAC androgen receptor protein degrader ARV-766 for the treatment of prostate cancer. The transaction closed in May 2024.
#TeamArvinas is made up of approximately 450 passionate and curious employees, whose diverse thoughts and perspectives are highly valued. Arvinas employees embrace the freedom to pursue innovation, think creatively, and give back. They are driven by the company’s values and mission – to improve the lives of patients with serious diseases by pioneering therapies created with our revolutionary PROTAC protein degradation platform.
The Associate Director, Commercial Insights and Analytics, Early Pipeline will be responsible for providing strategic commercial and competitive intelligence insights for preclinical and clinical programs, and new target assessments to support Arvinas’ portfolio. This includes developing a strong viewpoint on evolving treatment landscape and unmet needs, and competitive landscape for Arvinas’ preclinical and clinical programs. This role offers an opportunity to help shape the strategy to deliver a new transformative drug modality to patients with high unmet needs.
This position reports to the Executive Director, Commercial Insights and Analytics, and can be located at our headquarters in New Haven, CT or work remotely from a location within the U.S.
Key responsibilities of this role include, but are not limited to:
Qualifications:
Education:
Arvinas is proud to offer a competitive package of base and incentive compensation as well as a comprehensive benefits program designed to support the health, wellness and financial security of our employees and their families. Benefits include group medical, vision and dental coverage, group and supplemental life insurance, and much more.
Arvinas is an Equal Opportunity employer.